We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Inhibition of human oral squamous cell carcinoma proliferation and migration by prodrug-activating suicide gene therapies.
- Authors
Xu, Naining; Tian, Honglei; Po Fung, Chun; Lin, Yuntao; Chen, Yuling; Zhu, Guang; Shen, Yuehong; Guo, Chuanbin; Yang, Hongyu
- Abstract
Head and neck squamous cell carcinoma (HNSCC), which originates from mucosal epithelium in the oral cavity, pharynx and larynx, is the sixth most common malignancy in the world. The prognosis of HNSCC is not satisfactory due to metastasis, resulting in 5-year survival rates ranging from 65.9 to 67.2%. Previously, we developed a method to evaluate the effect prodrug-activating suicide gene (PA-SG) therapy on the proliferation of HNSCC. The present study investigated PA-SG therapy on metastatic HNSCC by wound-healing assay and our previously established method. HSC-3 cells with stable expression of suicide genes thymidine kinase (TK) or cytosine deaminase (CD) were treated with prodrugs ganciclovir (GCV) or 5-fluorocytosine (5-FC), respectively. Both GCV and 5-FC inhibited HSC-3 proliferation while the bystander effect of CD/5-FC was greater compared with that of TK/GCV. GCV showed a greater anti-migration effect compared with that of 5-FC. To the best of our knowledge, the present study is the first to evaluate the anti-migratory and anti-proliferative effects of PA-SG therapies on metastatic HNSCC. This may also serve as a general method to quantify other types of PA-SC therapy. The present results demonstrated that PA-SG therapy is a promising treatment for anti-metastatic HNSCC therapy development.
- Subjects
SQUAMOUS cell carcinoma; GENE therapy; PRODRUGS; CELL proliferation; SUICIDE victims; THYMIDINE
- Publication
Experimental & Therapeutic Medicine, 2023, Vol 25, Issue 2, pN.PAG
- ISSN
1792-0981
- Publication type
Article
- DOI
10.3892/etm.2023.11790